Michael Seiberling
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Pneumonia and Respiratory Infections 3
- Co-authors
- Bin Peng (5 shared papers)Rolf Pokorny (6 shared papers)Renaud Capdeville (4 shared papers)Michael Hayes (3 shared papers)Catherine Dutreix (2 shared papers)Monique Ben‐Am (2 shared papers)Felix Waldmeier (2 shared papers)U Keller (2 shared papers)
- Journals
- The Journal of Clinical Pharmacology (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Vaccine (3 papers)Clinical Therapeutics (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Michael Seiberling
43 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Hematology 399
- Genetics 225
- Pharmacology 142
- Gastroenterology 79
- Pharmaceutical Science 70
Countries citing papers authored by Michael Seiberling
This map shows the geographic impact of Michael Seiberling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Seiberling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Seiberling more than expected).
Fields of papers citing papers by Michael Seiberling
This network shows the impact of papers produced by Michael Seiberling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Seiberling. The network helps show where Michael Seiberling may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Seiberling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 187 | |
| 2 | 2004 | 131 | |
| 3 | 2004 | 126 | |
| 4 | 2004 | 122 | |
| 5 | 2007 | 104 | |
| 6 | 2008 | 99 | |
| 7 | 2012 | 82 | |
| 8 | 1997 | 77 | |
| 9 | 2012 | 68 | |
| 10 | 2012 | 58 | |
| 11 | 2009 | 49 | |
| 12 | 2004 | 46 | |
| 13 | 1996 | 46 | |
| 14 | 2009 | 45 | |
| 15 | 2009 | 44 | |
| 16 | 2007 | 31 | |
| 17 | 2009 | 28 | |
| 18 | 2001 | 23 | |
| 19 | 2011 | 23 | |
| 20 | 2009 | 23 |
About Michael Seiberling
Michael Seiberling is a scholar working on Epidemiology, Molecular Biology, Pharmacology, Hematology and Immunology, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Olfactory and Sensory Function Studies (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Hematology (399 citations), Genetics (225 citations), Pharmacology (142 citations), Gastroenterology (79 citations) and Pharmaceutical Science (70 citations). Michael Seiberling has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Bin Peng, Rolf Pokorny, Renaud Capdeville, Michael Hayes, Catherine Dutreix, Monique Ben‐Am, Felix Waldmeier, U Keller, Martine Hubert and Axel Krebs‐Brown. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Cancer Chemotherapy and Pharmacology, Vaccine and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.